OncoBone has released the schedule for events and conferences for 2022. Next year will take us to a mix of scientific and partnering events, hopefully some of which will be arranged in-person. From this blog post you may read more on what events we are participating in 2022 and what are our aims and expectations for these events.
Event calendar for 2022
The event year will start by attending Biotech Showcase, an event brings together global investors and biotech innovators. OncoBone will attend the virtual event during January 17-19. Our primary goals in the event are to discuss partnership opportunities and fundraising for OncoBone Ventures.
Two of the events will be held in Helsinki, Finland. First of them is ChemBio Finland on March 30-31 that brings together chemistry and biotechnology professionals from Nordic Countries and Baltic region. OncoBone is attending the event mainly to meet existing contacts and network with new contacts from our home region.
BIO-Europe Spring is planned to be a hybrid event, the virtual part being held on April 4-6, a week after the in-person part that will be held in Basel, Switzerland. Based on our previous experience OncoBone expects BIO-Europe to be a great event to participate for exploring new partnership opportunities.
The leading oncology scientific event American Association for Cancer Research (AACR) Annual Meeting will be held on April 8-13 in New Orleans, LA, USA. The meeting is planned to be arranged in hybrid format to allow everyone interested to participate. OncoBone has submitted an abstract to the event describing our recent findings on genetic changes in breast and prostate cancer bone metastasis. We are delighted to present and discuss our findings with colleagues in the event.
The second exciting event arranged in Helsinki is the European Calcified Tissue Society (ECTS) Congress on May 7-10. ECTS Congress in the leading European event for bone and musculoskeletal research. OncoBone has submitted two abstracts to the event, one describing positioning of Dual-energy X-ray Absorptiometry (DXA) as an imaging device in bone and metabolic research, and the other describing a novel human 3D cartilage-on-chip technology for osteoarthritis drug development. We are delighted to describe advantages of these technologies in the event.
BIO International Convention that will be held on June 13-16 will be one of the highlights of the event year for OncoBone. The format of the event is to be announced later. Depending on the progress made earlier in the year, the main goal in the event will be either partnering or fundraising.
The American Society for Bone and Mineral Research (ASBMR) Annual Meeting is planned to be held in-person in Austin, TX, USA on September 9-12. OncoBone is planning to submit 1-2 abstracts to the event before the abstract submission deadline in summer, but the contents remain to be finalized. If you would like to publish and present something together with us, we would be happy to evaluate this opportunity.
According to our current plans the event year will end with BIO-Europe arranged on October 24-26 in Leipzig, Germany. The aims for this event will be placed based on other developments during the year.
Meet us and discuss about collaboration opportunities
OncoBone is always available to discuss any collaboration opportunities whether it is during or outside of events. If you happen to be attending the same events, we would be happy to arrange a possibility to meet also face-to-face.
You may contact us at email@example.com.